Ligand validation:5XA7

PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE

PCW is a Ligand Of Interest in 5XA7 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
5XA7_PCW_A_1036	7%	55%	0.26	0.828	0.68	1.06	-	1	0	41%	0.4074
5XA7_PCW_A_1011	4%	21%	0.313	0.789	0.72	2.52	-	4	0	41%	0.4074
5XA7_PCW_A_1007	2%	50%	0.371	0.733	0.67	1.26	1	2	0	41%	0.4074
5XA7_PCW_A_1020	0%	53%	0.475	0.569	0.73	1.07	-	1	0	41%	0.4074
5XA7_PCW_A_1025	0%	48%	0.515	0.602	0.75	1.25	-	2	0	41%	0.4074
5XA7_PCW_A_1019	0%	47%	0.475	0.546	0.78	1.25	-	2	0	41%	0.4074
5XA7_PCW_A_1027	0%	52%	0.56	0.539	0.83	1.04	-	1	0	41%	0.4074
5XA7_PCW_A_1013	0%	50%	0.452	0.415	0.67	1.24	-	2	0	41%	0.4074
5XA7_PCW_A_1031	0%	56%	0.585	0.545	0.67	1.02	-	1	0	41%	0.4074
5XA7_PCW_A_1021	0%	55%	0.537	0.49	0.74	0.99	-	-	0	41%	0.4074
5XA7_PCW_A_1005	0%	54%	0.634	0.566	0.7	1.08	-	2	1	41%	0.4074
5XA7_PCW_A_1022	0%	47%	0.589	0.506	1	1.03	1	1	2	41%	0.4074
5XA7_PCW_A_1037	0%	55%	0.609	0.501	0.72	1.02	-	1	0	41%	0.4074
5XA7_PCW_A_1006	0%	46%	0.7	0.568	0.81	1.27	1	2	0	41%	0.4074
5XA7_PCW_A_1016	0%	50%	0.561	0.432	0.69	1.24	-	2	0	41%	0.4074
5XA7_PCW_A_1024	0%	54%	0.601	0.478	0.74	1.02	-	1	0	41%	0.4074
5XA7_PCW_A_1023	0%	55%	0.51	0.35	0.7	1.01	-	1	0	41%	0.4074
5XA7_PCW_A_1008	0%	49%	0.743	0.486	0.7	1.25	-	2	0	41%	0.4074
5XA7_PCW_A_1015	0%	49%	0.689	0.368	0.91	1.05	-	2	0	41%	0.4074
5XA7_PCW_A_1004	0%	54%	0.924	0.562	0.76	1.02	-	1	0	41%	0.4074
5XA7_PCW_A_1030	0%	52%	0.736	0.389	0.81	1.04	-	1	0	41%	0.4074
5XA7_PCW_A_1035	0%	52%	0.7	0.279	0.83	1.04	-	1	0	41%	0.4074
5XA7_PCW_A_1012	0%	56%	0.79	0.358	0.61	1.08	-	1	0	41%	0.4074
5XA7_PCW_A_1010	0%	50%	0.751	0.259	0.85	1.07	-	1	0	41%	0.4074
5XA7_PCW_A_1014	0%	54%	0.782	0.296	0.75	1.01	-	1	0	41%	0.4074
5XA7_PCW_A_1018	0%	51%	0.718	0.294	0.88	1.02	-	1	0	41%	0.4074
5XA7_PCW_A_1026	0%	55%	0.869	0.343	0.65	1.06	-	1	0	41%	0.4074
5XA7_PCW_A_1028	0%	51%	1.142	0.265	0.79	1.09	-	2	0	41%	0.4074
5XA7_PCW_A_1029	0%	50%	1.191	0.288	0.9	1.04	-	1	0	41%	0.4074
5XA7_PCW_A_1032	0%	54%	1.02	0.372	0.73	1.05	-	1	0	41%	0.4074
5XA7_PCW_A_1034	0%	54%	0.988	0.138	0.75	1.01	-	1	0	41%	0.4074
5XA7_PCW_A_1009	0%	55%	0.883	0.093	0.7	1.03	-	1	0	41%	0.4074
5XA7_PCW_A_1033	0%	52%	1.159	0.413	0.81	1.06	-	1	0	41%	0.4074
5XA7_PCW_A_1017	0%	50%	1.204	0.118	0.9	1.02	-	1	0	41%	0.4074
4NAB_PCW_A_1103	30%	57%	0.216	0.881	0.99	0.67	1	2	4	100%	1
4UU1_PCW_A_1103	16%	30%	0.21	0.881	1.64	1.16	5	2	0	44%	0.4444
6HEF_PCW_A_1006	12%	43%	0.329	0.861	1.22	0.98	6	2	6	100%	0.9907
5XA8_PCW_A_1014	7%	50%	0.235	0.796	0.9	1.04	-	1	0	41%	0.4074
5XAB_PCW_A_1011	6%	53%	0.295	0.829	0.79	1.01	-	1	0	41%	0.4074
6ZHH_PCW_B_1009	47%	48%	0.198	0.937	0.99	1.01	5	4	3	100%	1
4F2A_PCW_A_607	26%	40%	0.215	0.857	1.28	1.05	4	6	3	100%	1
6JXI_PCW_B_303	25%	49%	0.265	0.903	0.91	1.05	2	3	2	100%	1
7WYT_PCW_C_1109	23%	46%	0.197	0.928	0.85	1.23	-	3	0	41%	0.4074
2A1L_PCW_A_501	20%	49%	0.279	0.884	1.42	0.58	3	-	1	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.

Prepare Data

Validate Data

Deposit Data

Help and Resources

5XA7

PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE

PCW is a Ligand Of Interest in 5XA7 designated by the RCSB